Devalued and Distrusted

A Pharma Veteran's View - Dr. John L. LaMattina is the former Senior Vice President of Pfizer, and President, Pfizer Global Research and Development. In this role, Dr. LaMattina oversaw the drug discovery and development efforts of over 12,000 colleagues around the world directed towards new treatments for diseases like cancer or AIDS. He retired from Pfizer in 2007 and is now a Senior Partner at PureTech Ventures and serves on the Boards of Ligand Pharmaceuticals and Trevena Pharmaceuticals.

read more